Thyroid vascularization by color Doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease

被引:48
|
作者
Baldini, M
Castagnone, D
Rivolta, R
Meroni, L
Pappalettera, M
Cantalamessa, L
机构
[1] Univ Milan, Ist Med Interna Malattie Infett & Immunopatol, Milan, Italy
[2] IRCCS, Osped Maggiore, Serv Radiol 1, Milan, Italy
[3] IRCCS, Osped Maggiore, Serv Radiol 2, Milan, Italy
[4] IRCCS, Osped Maggiore, Ctr Trasfus, Milan, Italy
关键词
D O I
10.1089/thy.1997.7.823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate possible correlations between thyroid vascularization and activity of Graves' disease, we measured blood flow (TBF) at the inferior thyroid artery and intraparenchymal vascularization (number of vessels per square centimeter) by color Doppler ultrasonography (CDU) on Graves' patients at different phases of the disease. We studied 88 patients cross sectionally: 22 untreated; 17 euthyroid after 6 months of methimazole; 49 euthyroid at drug withdrawal after 12 to 24 months of treatment. The patients of the latter group were followed up for 29.1 +/- 6.3 months after discontinuation of treatment. On the day of CDU examination, free triiodothyronine (FT3), free thyroxine (FT4), thyrotropin (TSH), antiperoxidase and anti-TSH receptor (TRAb) antibodies were measured. Vascularization indices were significantly higher in the Graves' patients than in controls. In the patients euthyroid under treatment, vascularization was not significantly lower than in the untreated group, but TBF and vessel number both appeared clearly reduced in the patients tested at drug withdrawal. The vascularization indices at drug withdrawal were significantly higher in the patients who relapsed than in those in stable remission: TBF (mL/min) 50.6 +/- 36.8 vs. 23.8 +/- 17.5, p = 0.001; vessel number/cm(2) 1.8 +/- 0.8 vs. 0.8 +/- 0.5, p = 0.002. A multivariate analysis, evaluating the predictive value of vascularization, hormonal and immunological parameters for relapse, demonstrated a significant predictive value for TRAb (RR 8.2; p = 0.001) and a weak predictive value for TBF (RR 1.1; p = 0.02). In conclusion, CDU examination confirms that thyroid hypervascularization in Graves' disease is not related to thyroid hormone circulating levels. The association of increased TBF and high levels of TRAb in the relapsing forms of disease suggests that thyroid hypervascularization is probably related to the activity of the underlying autoimmune processes.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 50 条
  • [41] Long-term outcomes of children with Lyme disease.
    Shapiro, ED
    Seltzer, EG
    Gerber, MA
    Cartter, ML
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1094 - 1094
  • [42] Long-Term Outcome of Kawasaki Disease
    Senzaki, Hideaki
    CIRCULATION, 2008, 118 (25) : 2763 - 2772
  • [43] Long-term outcomes of persons with Lyme disease.
    Seltzer, EG
    Gerber, MA
    Cartter, ML
    Shapiro, ED
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 1 - 1
  • [44] Long-term prognosis of Behcet's disease.
    Chen, LL
    Funamoto, Y
    Yamamoto, K
    Tanaka, M
    Shimakawa, M
    Hori, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S463 - S463
  • [45] Long-term cardiac sequelae of Kawasaki disease.
    Fulton D.R.
    Newburger J.W.
    Current Rheumatology Reports, 2000, 2 (4) : 324 - 329
  • [46] Long-term management of Graves disease: a narrative review
    Kim, Hyo-Jeong
    JOURNAL OF YEUNGNAM MEDICAL SCIENCE, 2023, 40 (01): : 12 - 22
  • [47] Long-term thionamide antithyroid treatment of Graves' disease
    Azizi, Fereidoun
    Abdi, Hengameh
    Amouzegar, Atieh
    Moeini, Ali Siamak Habibi
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (02)
  • [48] Positive Impact of Long-Term Antithyroid Drug Treatment on the Outcome of Children with Graves' Disease: National Long-Term Cohort Study
    Leger, Juliane
    Gelwane, Georges
    Kaguelidou, Florentia
    Benmerad, Meriem
    Alberti, Corinne
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01): : 110 - 119
  • [49] SERUM THYROGLOBULIN CHANGES IN PATIENTS WITH GRAVES-DISEASE TREATED WITH LONG-TERM ANTI-THYROID DRUG-THERAPY
    KAWAMURA, S
    KISHINO, B
    TAJIMA, K
    MASHITA, K
    TARUI, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (03): : 507 - 512
  • [50] Long-Term Outcome of Living Donor Liver Transplantation for Patients With Alcoholic Liver Disease.
    Hwang, Shin
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Park, Gil-Chun
    Lee, Sung-Gyu
    LIVER TRANSPLANTATION, 2014, 20 : S325 - S326